0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Drug Inhaler - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-15V14654
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Drug Inhaler Market Research Report 2023
BUY CHAPTERS

Drug Inhaler - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-15V14654
Report
October 2024
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Inhaler - Market Size

The global market for Drug Inhaler was estimated to be worth US$ 10900 million in 2023 and is forecast to a readjusted size of US$ 22180 million by 2030 with a CAGR of 10.8% during the forecast period 2024-2030

Drug Inhaler - Market

Drug Inhaler - Market

A drug inhaler is a medical device used to inhale medication directly into the lungs. It is commonly used for respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD)
The drug inhaler market has been steadily growing over the past few years and is expected to continue to grow in the near future. This growth can be attributed to several factors, including the increasing prevalence of respiratory diseases such as asthma and COPD, as well as the growing demand for convenient and easy-to-use inhalers. Inhalers are commonly used for the treatment of respiratory diseases as they deliver medication directly to the lungs, providing fast and effective relief of symptoms. The demand for inhalers has been driven by the increasing prevalence of respiratory diseases, particularly in developing countries where air pollution and smoking are major contributors to the problem.In addition, there is a growing trend towards the development of innovative inhaler technologies that improve drug delivery and patient compliance. For example, digital inhalers that track medication usage and provide real-time feedback to patients are becoming increasingly popular.Overall, the drug inhaler market is expected to continue to grow in the coming years, driven by the increasing prevalence of respiratory diseases and the development of innovative inhaler technologies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Inhaler, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drug Inhaler by region & country, by Type, and by Application.
The Drug Inhaler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Inhaler.
Market Segmentation

Scope of Drug Inhaler - Market Report

Report Metric Details
Report Name Drug Inhaler - Market
Forecasted market size in 2030 US$ 22180 million
CAGR 10.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Metered-dose Inhalers
  • Dry Powder Inhalers
  • Soft Mist Inhalers
Segment by Application
  • Household
  • Commercial
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Sensirion, 3M, Philips Healthcare, Teva Pharmaceutical Industries, GlaxoSmithKline, Hailie, Cohero Health, Glenmark Pharma, Novartis, OPKO Health, Boehringer Ingelheim, H&T Presspart Manufacturing Ltd., Personal Air Quality Systems, COHERO Health Inc., Cognita Labs, Pneuma Respiratory Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Drug Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Drug Inhaler in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Drug Inhaler in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Drug Inhaler - Market size in 2030?

Ans: The Drug Inhaler - Market size in 2030 will be US$ 22180 million.

Who are the main players in the Drug Inhaler - Market report?

Ans: The main players in the Drug Inhaler - Market are Pfizer, Sensirion, 3M, Philips Healthcare, Teva Pharmaceutical Industries, GlaxoSmithKline, Hailie, Cohero Health, Glenmark Pharma, Novartis, OPKO Health, Boehringer Ingelheim, H&T Presspart Manufacturing Ltd., Personal Air Quality Systems, COHERO Health Inc., Cognita Labs, Pneuma Respiratory Inc.

What are the Application segmentation covered in the Drug Inhaler - Market report?

Ans: The Applications covered in the Drug Inhaler - Market report are Household, Commercial, Other

What are the Type segmentation covered in the Drug Inhaler - Market report?

Ans: The Types covered in the Drug Inhaler - Market report are Metered-dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers

1 Market Overview
1.1 Drug Inhaler Product Introduction
1.2 Global Drug Inhaler Market Size Forecast
1.2.1 Global Drug Inhaler Sales Value (2019-2030)
1.2.2 Global Drug Inhaler Sales Volume (2019-2030)
1.2.3 Global Drug Inhaler Sales Price (2019-2030)
1.3 Drug Inhaler Market Trends & Drivers
1.3.1 Drug Inhaler Industry Trends
1.3.2 Drug Inhaler Market Drivers & Opportunity
1.3.3 Drug Inhaler Market Challenges
1.3.4 Drug Inhaler Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Inhaler Players Revenue Ranking (2023)
2.2 Global Drug Inhaler Revenue by Company (2019-2024)
2.3 Global Drug Inhaler Players Sales Volume Ranking (2023)
2.4 Global Drug Inhaler Sales Volume by Company Players (2019-2024)
2.5 Global Drug Inhaler Average Price by Company (2019-2024)
2.6 Key Manufacturers Drug Inhaler Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Drug Inhaler Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Drug Inhaler
2.9 Drug Inhaler Market Competitive Analysis
2.9.1 Drug Inhaler Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Drug Inhaler Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Inhaler as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Metered-dose Inhalers
3.1.2 Dry Powder Inhalers
3.1.3 Soft Mist Inhalers
3.2 Global Drug Inhaler Sales Value by Type
3.2.1 Global Drug Inhaler Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Inhaler Sales Value, by Type (2019-2030)
3.2.3 Global Drug Inhaler Sales Value, by Type (%) (2019-2030)
3.3 Global Drug Inhaler Sales Volume by Type
3.3.1 Global Drug Inhaler Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Drug Inhaler Sales Volume, by Type (2019-2030)
3.3.3 Global Drug Inhaler Sales Volume, by Type (%) (2019-2030)
3.4 Global Drug Inhaler Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Household
4.1.2 Commercial
4.1.3 Other
4.2 Global Drug Inhaler Sales Value by Application
4.2.1 Global Drug Inhaler Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Inhaler Sales Value, by Application (2019-2030)
4.2.3 Global Drug Inhaler Sales Value, by Application (%) (2019-2030)
4.3 Global Drug Inhaler Sales Volume by Application
4.3.1 Global Drug Inhaler Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Drug Inhaler Sales Volume, by Application (2019-2030)
4.3.3 Global Drug Inhaler Sales Volume, by Application (%) (2019-2030)
4.4 Global Drug Inhaler Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Drug Inhaler Sales Value by Region
5.1.1 Global Drug Inhaler Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Inhaler Sales Value by Region (2019-2024)
5.1.3 Global Drug Inhaler Sales Value by Region (2025-2030)
5.1.4 Global Drug Inhaler Sales Value by Region (%), (2019-2030)
5.2 Global Drug Inhaler Sales Volume by Region
5.2.1 Global Drug Inhaler Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Drug Inhaler Sales Volume by Region (2019-2024)
5.2.3 Global Drug Inhaler Sales Volume by Region (2025-2030)
5.2.4 Global Drug Inhaler Sales Volume by Region (%), (2019-2030)
5.3 Global Drug Inhaler Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Drug Inhaler Sales Value, 2019-2030
5.4.2 North America Drug Inhaler Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Drug Inhaler Sales Value, 2019-2030
5.5.2 Europe Drug Inhaler Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Drug Inhaler Sales Value, 2019-2030
5.6.2 Asia Pacific Drug Inhaler Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Drug Inhaler Sales Value, 2019-2030
5.7.2 South America Drug Inhaler Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Drug Inhaler Sales Value, 2019-2030
5.8.2 Middle East & Africa Drug Inhaler Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Inhaler Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Inhaler Sales Value
6.2.1 Key Countries/Regions Drug Inhaler Sales Value, 2019-2030
6.2.2 Key Countries/Regions Drug Inhaler Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Drug Inhaler Sales Value, 2019-2030
6.3.2 United States Drug Inhaler Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Inhaler Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Inhaler Sales Value, 2019-2030
6.4.2 Europe Drug Inhaler Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Inhaler Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Inhaler Sales Value, 2019-2030
6.5.2 China Drug Inhaler Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Inhaler Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Inhaler Sales Value, 2019-2030
6.6.2 Japan Drug Inhaler Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Inhaler Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Inhaler Sales Value, 2019-2030
6.7.2 South Korea Drug Inhaler Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Inhaler Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Inhaler Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Inhaler Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Inhaler Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Inhaler Sales Value, 2019-2030
6.9.2 India Drug Inhaler Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Inhaler Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Drug Inhaler Product Offerings
7.1.5 Pfizer Recent Development
7.2 Sensirion
7.2.1 Sensirion Company Information
7.2.2 Sensirion Introduction and Business Overview
7.2.3 Sensirion Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sensirion Drug Inhaler Product Offerings
7.2.5 Sensirion Recent Development
7.3 3M
7.3.1 3M Company Information
7.3.2 3M Introduction and Business Overview
7.3.3 3M Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.3.4 3M Drug Inhaler Product Offerings
7.3.5 3M Recent Development
7.4 Philips Healthcare
7.4.1 Philips Healthcare Company Information
7.4.2 Philips Healthcare Introduction and Business Overview
7.4.3 Philips Healthcare Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Philips Healthcare Drug Inhaler Product Offerings
7.4.5 Philips Healthcare Recent Development
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Company Information
7.5.2 Teva Pharmaceutical Industries Introduction and Business Overview
7.5.3 Teva Pharmaceutical Industries Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Teva Pharmaceutical Industries Drug Inhaler Product Offerings
7.5.5 Teva Pharmaceutical Industries Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Information
7.6.2 GlaxoSmithKline Introduction and Business Overview
7.6.3 GlaxoSmithKline Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GlaxoSmithKline Drug Inhaler Product Offerings
7.6.5 GlaxoSmithKline Recent Development
7.7 Hailie
7.7.1 Hailie Company Information
7.7.2 Hailie Introduction and Business Overview
7.7.3 Hailie Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hailie Drug Inhaler Product Offerings
7.7.5 Hailie Recent Development
7.8 Cohero Health
7.8.1 Cohero Health Company Information
7.8.2 Cohero Health Introduction and Business Overview
7.8.3 Cohero Health Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cohero Health Drug Inhaler Product Offerings
7.8.5 Cohero Health Recent Development
7.9 Glenmark Pharma
7.9.1 Glenmark Pharma Company Information
7.9.2 Glenmark Pharma Introduction and Business Overview
7.9.3 Glenmark Pharma Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Glenmark Pharma Drug Inhaler Product Offerings
7.9.5 Glenmark Pharma Recent Development
7.10 Novartis
7.10.1 Novartis Company Information
7.10.2 Novartis Introduction and Business Overview
7.10.3 Novartis Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Novartis Drug Inhaler Product Offerings
7.10.5 Novartis Recent Development
7.11 OPKO Health
7.11.1 OPKO Health Company Information
7.11.2 OPKO Health Introduction and Business Overview
7.11.3 OPKO Health Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.11.4 OPKO Health Drug Inhaler Product Offerings
7.11.5 OPKO Health Recent Development
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Company Information
7.12.2 Boehringer Ingelheim Introduction and Business Overview
7.12.3 Boehringer Ingelheim Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Boehringer Ingelheim Drug Inhaler Product Offerings
7.12.5 Boehringer Ingelheim Recent Development
7.13 H&T Presspart Manufacturing Ltd.
7.13.1 H&T Presspart Manufacturing Ltd. Company Information
7.13.2 H&T Presspart Manufacturing Ltd. Introduction and Business Overview
7.13.3 H&T Presspart Manufacturing Ltd. Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.13.4 H&T Presspart Manufacturing Ltd. Drug Inhaler Product Offerings
7.13.5 H&T Presspart Manufacturing Ltd. Recent Development
7.14 Personal Air Quality Systems
7.14.1 Personal Air Quality Systems Company Information
7.14.2 Personal Air Quality Systems Introduction and Business Overview
7.14.3 Personal Air Quality Systems Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Personal Air Quality Systems Drug Inhaler Product Offerings
7.14.5 Personal Air Quality Systems Recent Development
7.15 COHERO Health Inc.
7.15.1 COHERO Health Inc. Company Information
7.15.2 COHERO Health Inc. Introduction and Business Overview
7.15.3 COHERO Health Inc. Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.15.4 COHERO Health Inc. Drug Inhaler Product Offerings
7.15.5 COHERO Health Inc. Recent Development
7.16 Cognita Labs
7.16.1 Cognita Labs Company Information
7.16.2 Cognita Labs Introduction and Business Overview
7.16.3 Cognita Labs Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Cognita Labs Drug Inhaler Product Offerings
7.16.5 Cognita Labs Recent Development
7.17 Pneuma Respiratory Inc.
7.17.1 Pneuma Respiratory Inc. Company Information
7.17.2 Pneuma Respiratory Inc. Introduction and Business Overview
7.17.3 Pneuma Respiratory Inc. Drug Inhaler Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Pneuma Respiratory Inc. Drug Inhaler Product Offerings
7.17.5 Pneuma Respiratory Inc. Recent Development
8 Industry Chain Analysis
8.1 Drug Inhaler Industrial Chain
8.2 Drug Inhaler Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Inhaler Sales Model
8.5.2 Sales Channel
8.5.3 Drug Inhaler Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Drug Inhaler Market Trends
    Table 2. Drug Inhaler Market Drivers & Opportunity
    Table 3. Drug Inhaler Market Challenges
    Table 4. Drug Inhaler Market Restraints
    Table 5. Global Drug Inhaler Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Drug Inhaler Revenue Market Share by Company (2019-2024)
    Table 7. Global Drug Inhaler Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Drug Inhaler Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Drug Inhaler Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Drug Inhaler Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Drug Inhaler Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Drug Inhaler
    Table 13. Global Drug Inhaler Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Inhaler as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Drug Inhaler Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Drug Inhaler Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Drug Inhaler Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Drug Inhaler Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Drug Inhaler Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Drug Inhaler Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Drug Inhaler Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Drug Inhaler Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Drug Inhaler Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Drug Inhaler Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Drug Inhaler Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Drug Inhaler Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Drug Inhaler Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Drug Inhaler Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Drug Inhaler Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Drug Inhaler Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Drug Inhaler Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Drug Inhaler Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Drug Inhaler Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Drug Inhaler Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Drug Inhaler Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Drug Inhaler Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Drug Inhaler Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Drug Inhaler Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Drug Inhaler Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Drug Inhaler Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Drug Inhaler Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Drug Inhaler Sales Value by Region (2019-2024) & (%)
    Table 44. Global Drug Inhaler Sales Value by Region (2025-2030) & (%)
    Table 45. Global Drug Inhaler Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Drug Inhaler Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Drug Inhaler Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Drug Inhaler Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Drug Inhaler Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Drug Inhaler Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Drug Inhaler Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Drug Inhaler Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Drug Inhaler Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Drug Inhaler Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Drug Inhaler Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Drug Inhaler Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer Company Information
    Table 58. Pfizer Introduction and Business Overview
    Table 59. Pfizer Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer Drug Inhaler Product Offerings
    Table 61. Pfizer Recent Development
    Table 62. Sensirion Company Information
    Table 63. Sensirion Introduction and Business Overview
    Table 64. Sensirion Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Sensirion Drug Inhaler Product Offerings
    Table 66. Sensirion Recent Development
    Table 67. 3M Company Information
    Table 68. 3M Introduction and Business Overview
    Table 69. 3M Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. 3M Drug Inhaler Product Offerings
    Table 71. 3M Recent Development
    Table 72. Philips Healthcare Company Information
    Table 73. Philips Healthcare Introduction and Business Overview
    Table 74. Philips Healthcare Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Philips Healthcare Drug Inhaler Product Offerings
    Table 76. Philips Healthcare Recent Development
    Table 77. Teva Pharmaceutical Industries Company Information
    Table 78. Teva Pharmaceutical Industries Introduction and Business Overview
    Table 79. Teva Pharmaceutical Industries Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Teva Pharmaceutical Industries Drug Inhaler Product Offerings
    Table 81. Teva Pharmaceutical Industries Recent Development
    Table 82. GlaxoSmithKline Company Information
    Table 83. GlaxoSmithKline Introduction and Business Overview
    Table 84. GlaxoSmithKline Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. GlaxoSmithKline Drug Inhaler Product Offerings
    Table 86. GlaxoSmithKline Recent Development
    Table 87. Hailie Company Information
    Table 88. Hailie Introduction and Business Overview
    Table 89. Hailie Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Hailie Drug Inhaler Product Offerings
    Table 91. Hailie Recent Development
    Table 92. Cohero Health Company Information
    Table 93. Cohero Health Introduction and Business Overview
    Table 94. Cohero Health Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Cohero Health Drug Inhaler Product Offerings
    Table 96. Cohero Health Recent Development
    Table 97. Glenmark Pharma Company Information
    Table 98. Glenmark Pharma Introduction and Business Overview
    Table 99. Glenmark Pharma Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Glenmark Pharma Drug Inhaler Product Offerings
    Table 101. Glenmark Pharma Recent Development
    Table 102. Novartis Company Information
    Table 103. Novartis Introduction and Business Overview
    Table 104. Novartis Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Novartis Drug Inhaler Product Offerings
    Table 106. Novartis Recent Development
    Table 107. OPKO Health Company Information
    Table 108. OPKO Health Introduction and Business Overview
    Table 109. OPKO Health Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. OPKO Health Drug Inhaler Product Offerings
    Table 111. OPKO Health Recent Development
    Table 112. Boehringer Ingelheim Company Information
    Table 113. Boehringer Ingelheim Introduction and Business Overview
    Table 114. Boehringer Ingelheim Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Boehringer Ingelheim Drug Inhaler Product Offerings
    Table 116. Boehringer Ingelheim Recent Development
    Table 117. H&T Presspart Manufacturing Ltd. Company Information
    Table 118. H&T Presspart Manufacturing Ltd. Introduction and Business Overview
    Table 119. H&T Presspart Manufacturing Ltd. Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. H&T Presspart Manufacturing Ltd. Drug Inhaler Product Offerings
    Table 121. H&T Presspart Manufacturing Ltd. Recent Development
    Table 122. Personal Air Quality Systems Company Information
    Table 123. Personal Air Quality Systems Introduction and Business Overview
    Table 124. Personal Air Quality Systems Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Personal Air Quality Systems Drug Inhaler Product Offerings
    Table 126. Personal Air Quality Systems Recent Development
    Table 127. COHERO Health Inc. Company Information
    Table 128. COHERO Health Inc. Introduction and Business Overview
    Table 129. COHERO Health Inc. Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. COHERO Health Inc. Drug Inhaler Product Offerings
    Table 131. COHERO Health Inc. Recent Development
    Table 132. Cognita Labs Company Information
    Table 133. Cognita Labs Introduction and Business Overview
    Table 134. Cognita Labs Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Cognita Labs Drug Inhaler Product Offerings
    Table 136. Cognita Labs Recent Development
    Table 137. Pneuma Respiratory Inc. Company Information
    Table 138. Pneuma Respiratory Inc. Introduction and Business Overview
    Table 139. Pneuma Respiratory Inc. Drug Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Pneuma Respiratory Inc. Drug Inhaler Product Offerings
    Table 141. Pneuma Respiratory Inc. Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Drug Inhaler Downstream Customers
    Table 145. Drug Inhaler Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug Inhaler Product Picture
    Figure 2. Global Drug Inhaler Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Drug Inhaler Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Drug Inhaler Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Drug Inhaler Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Drug Inhaler Report Years Considered
    Figure 7. Global Drug Inhaler Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Drug Inhaler Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug Inhaler Revenue in 2023
    Figure 10. Drug Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Metered-dose Inhalers Picture
    Figure 12. Dry Powder Inhalers Picture
    Figure 13. Soft Mist Inhalers Picture
    Figure 14. Global Drug Inhaler Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Drug Inhaler Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Drug Inhaler Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Drug Inhaler Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Drug Inhaler Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Household
    Figure 20. Product Picture of Commercial
    Figure 21. Product Picture of Other
    Figure 22. Global Drug Inhaler Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Drug Inhaler Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Drug Inhaler Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Drug Inhaler Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Drug Inhaler Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Drug Inhaler Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Drug Inhaler Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Drug Inhaler Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Drug Inhaler Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Drug Inhaler Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Drug Inhaler Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Drug Inhaler Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Drug Inhaler Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Drug Inhaler Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Drug Inhaler Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Drug Inhaler Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Drug Inhaler Sales Volume (%), (2019-2030)
    Figure 39. United States Drug Inhaler Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Drug Inhaler Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Drug Inhaler Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Drug Inhaler Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Drug Inhaler Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Drug Inhaler Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Drug Inhaler Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Drug Inhaler Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Drug Inhaler Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Drug Inhaler Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Drug Inhaler Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Drug Inhaler Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Drug Inhaler Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Drug Inhaler Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Drug Inhaler Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Drug Inhaler Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Drug Inhaler Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Drug Inhaler Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Drug Inhaler Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Drug Inhaler Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Drug Inhaler Sales Value by Application (%), 2023 VS 2030
    Figure 60. Drug Inhaler Industrial Chain
    Figure 61. Drug Inhaler Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS